UK markets closed

Mesoblast Limited (MEOBF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.76000.0000 (0.00%)
At close: 01:52PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 812.35M
Enterprise value 857.20M
Trailing P/E N/A
Forward P/E 769.23
PEG ratio (5-yr expected) N/A
Price/sales (ttm)85.35
Price/book (mrq)1.70
Enterprise value/revenue 114.80
Enterprise value/EBITDA -17.60

Trading information

Stock price history

Beta (5Y monthly) 2.59
52-week change 324.59%
S&P500 52-week change 323.57%
52-week high 31.0000
52-week low 30.1000
50-day moving average 30.3900
200-day moving average 30.3181

Share statistics

Avg vol (3-month) 390.03k
Avg vol (10-day) 379.36k
Shares outstanding 51.14B
Implied shares outstanding 61.14B
Float 8796.46M
% held by insiders 121.88%
% held by institutions 19.51%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-784.65%

Management effectiveness

Return on assets (ttm)-5.61%
Return on equity (ttm)-14.49%

Income statement

Revenue (ttm)7.47M
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-11.70%
Gross profit (ttm)N/A
EBITDA -57.88M
Net income avi to common (ttm)-73.06M
Diluted EPS (ttm)-0.0900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)77.55M
Total cash per share (mrq)0.08
Total debt (mrq)122M
Total debt/equity (mrq)23.98%
Current ratio (mrq)2.71
Book value per share (mrq)0.50

Cash flow statement

Operating cash flow (ttm)-59.1M
Levered free cash flow (ttm)-63.95M